Cambridge engineering AI pioneer Monumo has promoted former CTO Dr Jarek Rzepecki to the CEO role in place of co-founder and ...

Eli Lilly and Company (Lilly) is acquiring Centessa Pharmaceuticals plc in a deal worth up to $7.8 billion ($6.3bn upfront ...

An email to the company itself had also failed to elicit a response at the time of going to Press but in a tough trading ...

Cambridge-based Broken String Biosciences, a biotech enabling gene editing teams to accelerate development of safer and more ...

AIM-quoted 4basebio, a specialist in synthetic DNA manufacturing and nucleic acids for nextgen therapeutics, is building for ...

The University of Cambridge plans to establish the Rokos School of Government following a commitment of £190 million from ...

University of Cambridge spin-out Semarion has secured $3.8 million funding in a round led by Parkwalk, and joined by The FSE ...

Microcomputing company Raspberry Pi has unveiled a superb set of results for the year to December 31 2025. Revenue for the ...

Transatlantic trailblazer Nuclera, a biotech company with homes in Cambridge UK and Boston in the US, continues to create new ...

CMR Surgical reveals that more than 45,000 patients worldwide have now been treated using its Versius® Surgical Robotic System, marking a major milestone for the Cambridge company as it prepares to ...

The corporate team at law firm Mills & Reeve has advised the shareholders of Owen Mumford Holdings Limited in Oxfordshire on the sale of the company to Nasdaq-listed embecta Corporation.

IW Capital has invested in Lucida Medical, a Cambridge and UK healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and more accurately.